Biotechnology Vertex Pharmaceuticals Moves Beyond $10B Cystic Fibrosis Franchise, Pays Around $5B For Kidney Disease Player Alpine Immune Why Alpine Immune Sciences Stock Is Trading Higher Today? – Alpine Immune Sciences (NASDAQ:ALPN), Vertex Pharmaceuticals (NASDAQ:VRTX) Read more
Biotechnology Vertex’s Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept’s Potential Impact – Vertex Pharmaceuticals (NASDAQ:VRTX) Read more
Stockmarkets Vertex Pharma bets on kidney disease treatment with $4.9 billion Alpine Immune deal Reuters via biedexmarkets.com Read more
Biotechnology Why Is Alpine Immune Sciences Stock Trading Higher Today? – Alpine Immune Sciences (NASDAQ:ALPN) Read more